CVE-2024-10476 json
Default credentials are used in the above listed BD Diagnostic Solutions products.
published 2024-12-17 22 mo ago modified 2026-06-17 4 mo ago also EUVD-2024-33567
- cvss
- 8.0
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 14%
- public exploits
- 0
- none known
Summary
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
Vendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSMA-24-352-01 updated cvss 8.0
BD Diagnostic Solutions Products (Update A)
-
Becton, Dickinson and Company (BD) BD BACTEC Blood Culture System Becton, Dickinson and Company (BD) BD COR System Becton, Dickinson and Company (BD) BD EpiCenter Microbiology Data Management System Becton, Dickinson and Company (BD) BD MAX System Becton, Dickinson and Company (BD) BD Phoenix M50 Automated Microbiology Systemaffected: mitigation “The BD RSS platform has not been impacted by and is not in scope of this vulnerability.” bd.com
-
Becton, Dickinson and Company (BD) BD Synapsys Informatics Solutionaffected: vendor fix, mitigation “The BD RSS platform has not been impacted by and is not in scope of this vulnerability.” bd.com
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 22 mo ago
Exploit prediction
0.24% chance of exploitation in the next 30 days, higher than 14% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 8.0 | CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
Affected products
- Becton Dickinson & Co BD BACTEC™ Blood Culture System
- Becton Dickinson & Co BD COR™ System
- Becton Dickinson & Co BD EpiCenter™ Microbiology Data Management System
- Becton Dickinson & Co BD MAX™ System
- Becton Dickinson & Co BD Phoenix™ M50 Automated Microbiology System
- Becton Dickinson & Co BD Synapsys™ Informatics Solution
Classification
- Weakness
-
- CWE-1392 Use of Default Credentials
References
Sources
- CVE List CVE-2024-10476
- NVD CVE-2024-10476
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.